Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Nides

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 20, 2018
Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic SettingMitchell Nides, Tobias Danielsson, Frederick Saunders, et al.
American Journal of Health Behavior|February 24, 2004
Comparative testing of 5 nicotine systems: initial use and preferencesNina G Schneider, Richard E Olmstead, Mitchell Nides, et al.
JAMA|July 11, 2023
Cytisinicline for Smoking Cessation: A Randomized Clinical TrialNancy A Rigotti, Neal L Benowitz, Judith Prochaska, et al.
American Journal of Health Behavior|April 30, 2008
Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysisMitchell Nides, Elbert D Glover, Victor I Reus, et al.
American Journal of Health Behavior|August 19, 2007
Hollywood quits--behind the scenes of a Hollywood-based smoking cessation programMitchell Nides, Lisa M Hund, Sharon Carothers, et al.
Drug Testing and Analysis|June 17, 2022
Examination of the impact of myblu electronic nicotine delivery system e-liquid nicotine strength on self-reported measures of dependenceIan M Fearon, Ryan G N Seltzer, Trisha L Houser, et al.
Drug Testing and Analysis|March 6, 2023
Curiosity and intentions to use myblu e-cigarettes and an examination of the 'gateway' theory: Data from cross-sectional nationally representative surveysIan M Fearon, Ryan G N Seltzer, Trisha L Houser, et al.
JAMA|July 6, 2006
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trialDavid Gonzales, Stephen I Rennard, Mitchell Nides, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 20, 2018
Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic SettingMitchell Nides, Tobias Danielsson, Frederick Saunders, et al.
American Journal of Health Behavior|February 24, 2004
Comparative testing of 5 nicotine systems: initial use and preferencesNina G Schneider, Richard E Olmstead, Mitchell Nides, et al.
JAMA|July 11, 2023
Cytisinicline for Smoking Cessation: A Randomized Clinical TrialNancy A Rigotti, Neal L Benowitz, Judith Prochaska, et al.
American Journal of Health Behavior|April 30, 2008
Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysisMitchell Nides, Elbert D Glover, Victor I Reus, et al.
American Journal of Health Behavior|August 19, 2007
Hollywood quits--behind the scenes of a Hollywood-based smoking cessation programMitchell Nides, Lisa M Hund, Sharon Carothers, et al.
Drug Testing and Analysis|June 17, 2022
Examination of the impact of myblu electronic nicotine delivery system e-liquid nicotine strength on self-reported measures of dependenceIan M Fearon, Ryan G N Seltzer, Trisha L Houser, et al.
Drug Testing and Analysis|March 6, 2023
Curiosity and intentions to use myblu e-cigarettes and an examination of the 'gateway' theory: Data from cross-sectional nationally representative surveysIan M Fearon, Ryan G N Seltzer, Trisha L Houser, et al.
JAMA|July 6, 2006
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trialDavid Gonzales, Stephen I Rennard, Mitchell Nides, et al.
Pageof 2